ArrayExpress Uploaderarrayexpress_sid26986068 yearsfemaleHD-MTX chemotherapyaliveless than 1 year5067 yearsfemaleHD-MTX chemotherapyalive1-2 years7064 yearsmaleHD-MTX chemotherapyalivemore than 3 years7072 yearsfemaleHD-MTX chemotherapyalivemore than 3 years4071 yearsfemaleHD-MTX chemotherapydead1-2 years7050 yearsmaleHD-MTX chemotherapyalivemore than 3 years5068 yearsfemaleHD-MTX chemotherapydead2-3 years5044 yearsmaleHD-MTX chemotherapydead2-3 years6076 yearsmaleHD-MTX chemotherapydead1-2 years8063 yearsmaleHD-MTX chemotherapydead2-3 years8064 yearsmaleHD-MTX chemotherapysurvivalmore than 3 years5059 yearsfemaleHD-MTX chemotherapydeadmore than 3 years5063 yearsmalenot specifiedsurvivalless than 1 year6057 yearsmaleHD-MTX chemotherapydeadless than 1 year4068 yearsfemaleHD-MTX chemotherapysurvivalless than 1 year10062 yearsmaleHD-MTX-containing polychemotherapydeadmore than 3 years6068 yearsfemaleHD-MTX-containing polychemotherapydeadmore than 3 years9057 yearsfemaleHD-MTX chemotherapydead2-3 years7074 yearsmaleHD-MTX chemotherapysurvivalmore than 3 years7059 yearsfemaleHD-MTX-containing polychemotherapydead1-2 years9068 yearsfemaleHD-MTX-containing polychemotherapydeadmore than 3 years7047 yearsmalenot specifieddeadmore than 3 years8058 yearsmaleHD-MTX-containing polychemotherapyalivemore than 3 years5069 yearsmalenot specifieddeadmore than 3 years10068 yearsmaleHD-MTX-containing polychemotherapydeadless than 1 year6066 yearsfemaleHD-MTX-containing polychemotherapydeadmore than 3 years10070 yearsfemaleHD-MTX-containing polychemotherapydead2-3 years7070 yearsmaleHD-MTX-containing polychemotherapydead2-3 years7063 yearsfemaleHD-MTX-containing polychemotherapydead1-2 years8071 yearsfemaleHD-MTX-containing polychemotherapyalivemore than 3 years10062 yearsmalenot specifieddead1-2 years7055 yearsmaleHD-MTX-containing polychemotherapydeadless than 1 year7073 yearsmaleHD-MTX-containing polychemotherapydeadmore than 3 years6065 yearsmaleHD-MTX-containing polychemotherapydeadmore than 3 years04This study aimed to define the genes associated with PCNSL patient survival. Expression profiling was performed on 34 PCNSLs. A gene...22908096/profile/8773/arrayexpressuploader634Dec.12, 2014FalseE-GEOD-34771_A-AFFY-44expression-data-from-primary-central-nervous-systehttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34771Expression data from primary central nervous system lymphoma (PCNSL) patientsJul.12, 2014This study aimed to define the genes associated with PCNSL patient survival. Expression profiling was performed on 34 PCNSLs. A gene classifier was developed. Thirty-four PCNSL patients were selected for RNA extraction and hybridization on Affymetrix microarrays.E-GEOD-34771humanhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34771/samples/